{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:38:43Z","timestamp":1785523123384,"version":"3.56.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12461-y","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:57:43Z","timestamp":1785149863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aptamer-mediated targeting of CXCR3-B in acute lymphoblastic leukemia nalm-6 cells: an in silico and in vitro study"],"prefix":"10.1007","volume":"53","author":[{"given":"Hossein","family":"Arezoomand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Jebali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar Mardani","family":"Valandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nooshadokht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Afgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Hossein","family":"Ashoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roohollah Mirzaee","family":"Khalilabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"1","key":"12461_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-024-00525-x","volume":"10","author":"L Pagliaro","year":"2024","unstructured":"Pagliaro L, Chen S-J, Herranz D, Mecucci C, Harrison CJ, Mullighan CG et al (2024) Acute lymphoblastic leukaemia. Nat Rev Dis Primers 10(1):41","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"12461_CR2","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/his.15338","volume":"86","author":"W Walter","year":"2025","unstructured":"Walter W, Iacobucci I, Meggendorfer M (2025) Diagnosis of acute lymphoblastic leukaemia: an overview of the current genomic classification, diagnostic approaches, and future directions. Histopathology 86(1):134\u2013145","journal-title":"Histopathology"},{"issue":"1","key":"12461_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/hon.2936","volume":"40","author":"Y Hu","year":"2022","unstructured":"Hu Y, Zhang X, Zhang A, Hou Y, Liu Y, Li Q et al (2022) Global burden and attributable risk factors of acute lymphoblastic leukemia in 204 countries and territories in 1990\u20132019: estimation based on Global Burden of Disease Study 2019. Hematol Oncol 40(1):93\u2013105","journal-title":"Hematol Oncol"},{"issue":"2","key":"12461_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.medp.2025.100087","volume":"2","author":"H Miao","year":"2025","unstructured":"Miao H, Fang Y, Pan C, Yang H, Wang Z, Qi Y et al (2025) Transforming the landscape of cancer treatment with seven promising novel therapies: evolution and future perspectives. Medicine Plus 2(2):100087","journal-title":"Medicine Plus"},{"key":"12461_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1022688","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang Y, Wang S, Ni H, Zhao P, Chen G et al (2022) The role of CXCR3 and its ligands in cancer. Front Oncol 12:1022688","journal-title":"Front Oncol"},{"key":"12461_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1556196","volume":"16","author":"R Huo","year":"2025","unstructured":"Huo R, Jiang Y, Zhang L, Du S, Zhou D (2025) CXCR3 inhibitors for therapeutic interventions: current status and perspectives. Front Pharmacol 16:1556196","journal-title":"Front Pharmacol"},{"key":"12461_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.868579","volume":"13","author":"G D\u2019Uonnolo","year":"2022","unstructured":"D\u2019Uonnolo G, Reynders N, Meyrath M, Abboud D, Ucha\u0144ski T, Laeremans T et al (2022) The extended N-terminal domain confers atypical chemokine receptor properties to CXCR3-B. Front Immunol 13:868579","journal-title":"Front Immunol"},{"issue":"1","key":"12461_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-8722-6-42","volume":"6","author":"K Pilatova","year":"2013","unstructured":"Pilatova K, Greplova K, Demlova R, Bencsikova B, Klement GL, Zdrazilova-Dubska L (2013) Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology. J Hematol Oncol 6(1):1\u20138","journal-title":"J Hematol Oncol"},{"issue":"9","key":"12461_CR9","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.7314\/APJCP.2014.15.9.3939","volume":"15","author":"TAD Al-Astani Tengku Din","year":"2014","unstructured":"Al-Astani Tengku Din TAD, Shamsuddin SH, Idris FM, Wan Mansor WNA, Abdul Jalal MI, Jaafar H (2014) Rapamycin and PF4 induce apoptosis by upregulating Bax and down-regulating survivin in MNU-induced breast cancer. Asian Pac J Cancer Prev 15(9):3939\u20133944","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"12461_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.canlet.2013.01.006","volume":"331","author":"Z Wang","year":"2013","unstructured":"Wang Z, Huang H (2013) Platelet factor-4 (CXCL4\/PF-4): an angiostatic chemokine for cancer therapy. Cancer Lett 331(2):147\u2013153","journal-title":"Cancer Lett"},{"issue":"3","key":"12461_CR11","first-page":"303","volume":"40","author":"TADAA Tengku","year":"2018","unstructured":"Tengku TADAA, Jalal MIA, Seeni A, Shamsuddin S, Jaafar H (2018) The differential roles of caspase family members in mediating PF4-induced breast cancer apoptosis. Malays J Pathol 40(3):303\u2013312","journal-title":"Malays J Pathol"},{"issue":"22","key":"12461_CR12","doi-asserted-by":"publisher","first-page":"12471","DOI":"10.1021\/acs.chemrev.3c00377","volume":"123","author":"C Ji","year":"2023","unstructured":"Ji C, Wei J, Zhang L, Hou X, Tan J, Yuan Q et al (2023) Aptamer\u2013protein interactions: from regulation to biomolecular detection. Chem Rev 123(22):12471\u201312506","journal-title":"Chem Rev"},{"issue":"4","key":"12461_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s40242-022-2087-9","volume":"38","author":"S Chen","year":"2022","unstructured":"Chen S, Zhang L, Yuan Q, Tan J (2022) Current advances in aptamer-based biomolecular recognition and biological process regulation. Chem Res Chin Univ 38(4):847\u2013855","journal-title":"Chem Res Chin Univ"},{"issue":"13","key":"12461_CR14","doi-asserted-by":"publisher","first-page":"6833","DOI":"10.3390\/ijms25136833","volume":"25","author":"M Domsicova","year":"2024","unstructured":"Domsicova M, Korcekova J, Poturnayova A, Breier A (2024) New Insights into Aptamers: An Alternative to Antibodies in the Detection of Molecular Biomarkers. Int J Mol Sci 25(13):6833","journal-title":"Int J Mol Sci"},{"issue":"26","key":"12461_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ange.202424687","volume":"137","author":"M He","year":"2025","unstructured":"He M, Wang Z, Wu X, Du Z, Cui C, Zhao Z et al (2025) Functional SELEX and biomedical applications of aptamers: beyond molecular recognition. Angew Chem 137(26):e202424687","journal-title":"Angew Chem"},{"issue":"6","key":"12461_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biom15060818","volume":"15","author":"L Feng","year":"2025","unstructured":"Feng L, Sun Y, Jia W, Yu Y, Liu C, Yang J et al (2025) Advancements in SELEX technology for aptamers and emerging applications in therapeutics and drug delivery. Biomolecules 15(6):818","journal-title":"Biomolecules"},{"key":"12461_CR17","doi-asserted-by":"crossref","unstructured":"D\u2019Uonnolo G, Reynders N, Meyrath M, Abboud D, Ucha\u0144ski T, Laeremans T et al. (2022) The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B. Frontiers in Immunology. Volume 13 - 2022.","DOI":"10.3389\/fimmu.2022.868579"},{"issue":"1","key":"12461_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11033-025-11106-w","volume":"52","author":"S Mostajeran","year":"2025","unstructured":"Mostajeran S, Ehsan M, Lashkari M, Valandani HM, Fatemi A, Bazi A et al (2025) Zataria multiflora extract enhances imatinib-induced cytotoxicity in chronic myeloid leukemia and multiple myeloma cells. Mol Biol Rep 52(1):1\u201313","journal-title":"Mol Biol Rep"},{"issue":"1","key":"12461_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-11532-7","volume":"15","author":"AH Alzaidy","year":"2025","unstructured":"Alzaidy AH, Ganduh SH, Abed MJ, Dawi EA, Jasim LS, Ashoub MH (2025) Microwave assisted solvothermal green synthesis of Fe3O4 nanoparticles using sea buckthorn for multiple myeloma and monocytic leukemia treatment. Sci Rep 15(1):25743","journal-title":"Sci Rep"},{"issue":"1","key":"12461_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85329-z","volume":"15","author":"MH Ashoub","year":"2025","unstructured":"Ashoub MH, Afgar A, Farsinejad A, Razavi R, Anvari S, Fatemi A (2025) siRNA-mediated inhibition of hTERT enhances the effects of curcumin in promoting cell death in precursor-B acute lymphoblastic leukemia cells: an in silico and in vitro study. Sci Rep 15(1):3083","journal-title":"Sci Rep"},{"issue":"4","key":"12461_CR21","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s10528-023-10565-9","volume":"62","author":"F Yari","year":"2024","unstructured":"Yari F, Ashoub MH, Amirizadeh N, Nikougoftar M, Valandani HM, Khalilabadi RM (2024) Differential expression of the hTERT gene in umbilical cord-derived mesenchymal stem cells cocultured with B cell precursor leukemia cell microparticles or CD41+\/CD61+ platelet microparticles. Biochem Genet 62(4):2796\u20132809","journal-title":"Biochem Genet"},{"issue":"8","key":"12461_CR22","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1007\/s12094-023-03126-4","volume":"25","author":"M Pan","year":"2023","unstructured":"Pan M, Wei X, Xiang X, Liu Y, Zhou Q, Yang W (2023) Targeting CXCL9\/10\/11\u2013CXCR3 axis: an important component of tumor-promoting and antitumor immunity. Clin Transl Oncol 25(8):2306\u20132320","journal-title":"Clin Transl Oncol"},{"issue":"14","key":"12461_CR23","doi-asserted-by":"publisher","first-page":"7677","DOI":"10.1021\/jacs.3c00841","volume":"145","author":"S Xie","year":"2023","unstructured":"Xie S, Sun W, Fu T, Liu X, Chen P, Qiu L et al (2023) Aptamer-based targeted delivery of functional nucleic acids. J Am Chem Soc 145(14):7677\u20137691","journal-title":"J Am Chem Soc"},{"issue":"21","key":"12461_CR24","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.3390\/cancers15215300","volume":"15","author":"W Szymanowski","year":"2023","unstructured":"Szymanowski W, Szymanowska A, Bielawska A, Lopez-Berestein G, Rodriguez-Aguayo C, Amero P (2023) Aptamers as potential therapeutic tools for ovarian cancer: Advancements and challenges. Cancers 15(21):5300","journal-title":"Cancers"},{"key":"12461_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1818316","volume":"17","author":"F Arshad","year":"2026","unstructured":"Arshad F, Chinnappan R, Mir T, Ahmed Z, Arora I, Khan MI et al (2026) Aptamers and aptamer-drug conjugates as synthetic immune modulators for cancer immunotherapy. Front Immunol 17:1818316","journal-title":"Front Immunol"},{"key":"12461_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.omtn.2018.11.012","volume":"14","author":"S Yoon","year":"2019","unstructured":"Yoon S, Wu X, Armstrong B, Habib N, Rossi JJ (2019) An RNA aptamer targeting the receptor tyrosine kinase PDGFR\u03b1 induces anti-tumor effects through STAT3 and p53 in glioblastoma. Mol Ther Nucleic Acids 14:131\u2013141","journal-title":"Mol Ther Nucleic Acids"},{"issue":"9","key":"12461_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024071","volume":"6","author":"CL Esposito","year":"2011","unstructured":"Esposito CL, Passaro D, Longobardo I, Condorelli G, Marotta P, Affuso A et al (2011) A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death. PLoS ONE 6(9):e24071","journal-title":"PLoS ONE"},{"issue":"6","key":"12461_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202300584","volume":"8","author":"H Zhou","year":"2024","unstructured":"Zhou H, Li Y, Wu W (2024) Aptamers: promising reagents in biomedicine application. Adv Biol 8(6):2300584","journal-title":"Adv Biol"},{"key":"12461_CR29","doi-asserted-by":"crossref","unstructured":"Chopra A, Kumar S, Basumatary S, Mohanta GC, Pandey SK (2025) The Medicinal Chemistry of Artificial Nucleic Acids and Therapeutic Oligonucleotides. Viral Oncology 269\u2013299","DOI":"10.1201\/9781003516651-18"},{"issue":"11","key":"12461_CR30","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.2174\/0929867330666221014111403","volume":"30","author":"A Graczyk","year":"2023","unstructured":"Graczyk A, Radzikowska-Cieciura E, Kaczmarek R, Pawlowska R, Chworos A (2023) Modified nucleotides for chemical and enzymatic synthesis of therapeutic RNA. Curr Med Chem 30(11):1320\u20131347","journal-title":"Curr Med Chem"},{"issue":"11","key":"12461_CR31","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.tibtech.2023.05.005","volume":"41","author":"D Ji","year":"2023","unstructured":"Ji D, Feng H, Liew SW, Kwok CK (2023) Modified nucleic acid aptamers: development, characterization, and biological applications. Trends Biotechnol 41(11):1360\u20131384","journal-title":"Trends Biotechnol"},{"key":"12461_CR32","doi-asserted-by":"crossref","unstructured":"Gao Y, Chen Z-C, Liu L, Yang J-J, Liu X-L, Chen Y et al (2005) Inhibitory Effect of Monoclonal Antibodies Against CXCR3-B NH2-Terminus on the Proliferation of U937 Cells. American Society of Hematology","DOI":"10.1182\/blood.V106.11.2216.2216"},{"issue":"56","key":"12461_CR33","doi-asserted-by":"publisher","first-page":"7343","DOI":"10.1038\/sj.onc.1209722","volume":"25","author":"V Martel","year":"2006","unstructured":"Martel V, Filhol O, Colas P, Cochet C (2006) P53-dependent inhibition of mammalian cell survival by a genetically selected peptide aptamer that targets the regulatory subunit of protein kinase CK2. Oncogene 25(56):7343\u20137353","journal-title":"Oncogene"},{"issue":"6","key":"12461_CR34","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1074\/jbc.M113.508044","volume":"289","author":"M Balan","year":"2014","unstructured":"Balan M, Pal S (2014) A novel CXCR3-B chemokine receptor-induced growth-inhibitory signal in cancer cells is mediated through the regulation of Bach-1 protein and Nrf2 protein nuclear translocation. J Biol Chem 289(6):3126\u20133137","journal-title":"J Biol Chem"},{"issue":"1","key":"12461_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/07357907.2024.2445528","volume":"43","author":"M Mosadegh","year":"2025","unstructured":"Mosadegh M, Noori Goodarzi N, Erfani Y (2025) A comprehensive insight into apoptosis: molecular mechanisms, signaling pathways, and modulating therapeutics. Cancer Invest 43(1):33\u201358","journal-title":"Cancer Invest"},{"key":"12461_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.992260","volume":"12","author":"SK Pandey","year":"2022","unstructured":"Pandey SK, Shteinfer-Kuzmine A, Chalifa-Caspi V, Shoshan-Barmatz V (2022) Non-apoptotic activity of the mitochondrial protein SMAC\/Diablo in lung cancer: novel target to disrupt survival, inflammation, and immunosuppression. Front Oncol 12:992260","journal-title":"Front Oncol"},{"key":"12461_CR37","doi-asserted-by":"publisher","DOI":"10.2174\/0115665240380871250518032318","author":"A Mishra","year":"2025","unstructured":"Mishra A, Pandey SK (2025) SMAC\/DIABLO: a guardian angel in boosting anticancer drug-induced apoptosis. Curr Mol Med. https:\/\/doi.org\/10.2174\/0115665240380871250518032318","journal-title":"Curr Mol Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12461-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12461-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12461-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:23:09Z","timestamp":1785518589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12461-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12461"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12461-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Kerman University of Medical Science Ethical & Research Committee (ethical code: IR.KMU.REC.1398.613). All methods were performed following relevant guidelines and applicable regulations.","order":4,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1278"}}